Indigo Capital Partners

Managing Partner Petr leads investment decisions, supported by Vice President Yaroslav, an Investment Director, and a network of venture partners. Petr's background combines institutional training at Brunswick Capital with personal angel investing, while Yaroslav brings experience from Citigroup and the Russian industrial sector.

Indigo Capital Partners is structured as a private equity firm, not a family office. It was co-founded in 2011 by multiple partners and invests third-party-style capital in direct equity and venture opportunities, rather than managing a single family's wealth.

The firm employs a mix of direct equity investments, venture capital rounds, and joint ventures. It also engages in asset management, with operational control of at least one portfolio company — Yusupov Hospital — indicating a hands-on approach beyond passive minority stakes.

Indigo's disclosed portfolio spans healthcare services, sports technology, industrial manufacturing, and consumer goods. Healthcare is the most visible vertical, driven by direct management of a Moscow hospital and oversight of Polymerbyt's financial operations.

Yes. The firm's website states that it makes direct and venture investments in Russia and abroad. Specific international holdings are not publicly disclosed, but the dual mandate is explicitly stated.

Since its 2011 founding, Indigo reports completing over 25 transactions and achieving seven full exits. No fund-level return metrics or individual deal IRRs have been publicly released.

There is no public evidence of a parent institution. Petr and his partners founded the firm independently. Prior professional links include Brunswick Capital and Citigroup, but Indigo itself is not a captive unit of any larger conglomerate.